Noradrenaline release in the rat subfornical organ area to blood pressure changes. 1998

J Tanaka, and Y Hayashi, and T Watai, and K Hori, and M Nomura
Department of Human Development, Department of Education for Handicapped Children, Naruto University of Education, Takashima, Naruto, Tokushima, 772-8502, Japan.

To verify whether noradrenergic inputs to the subfornical organ (SFO) are involved in the control system of arterial pressure, we investigated the effects of blood pressure changes on noradrealine (NA) release in the SFO and its surrounding sites using microdialysis techniques in rats. Hemorrhage (5 or 10 ml/kg) significantly increased the NA concentration in the region of the SFO, but did not cause significant changes in the sites away from the SFO. An elevation in arterial pressure following intravenous administration of the alpha-agonist metaraminol slightly decreased the NA level in the region of the SFO. These results imply that the noradrenergic neural inputs to the SFO area may be involved in the control of cardiovascular function.

UI MeSH Term Description Entries
D008297 Male Males
D008680 Metaraminol A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION. Isophenylephrine,Metaradrin,m-Hydroxynorephedrine,meta-Hydroxynorephedrine,Aramine,Araminol,Hydroxyphenylpropanolamine,Metaraminol Bitartrate,Metaraminol Bitartrate (1:1),Metaraminol Tartrate,m-Hydroxyphenylpropanolamine,Bitartrate, Metaraminol,Tartrate, Metaraminol,m Hydroxynorephedrine,m Hydroxyphenylpropanolamine,meta Hydroxynorephedrine
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002543 Cerebral Hemorrhage Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA. Brain Hemorrhage, Cerebral,Cerebral Parenchymal Hemorrhage,Hemorrhage, Cerebral,Intracerebral Hemorrhage,Hemorrhage, Cerebrum,Brain Hemorrhages, Cerebral,Cerebral Brain Hemorrhage,Cerebral Brain Hemorrhages,Cerebral Hemorrhages,Cerebral Parenchymal Hemorrhages,Cerebrum Hemorrhage,Cerebrum Hemorrhages,Hemorrhage, Cerebral Brain,Hemorrhage, Cerebral Parenchymal,Hemorrhage, Intracerebral,Hemorrhages, Cerebral,Hemorrhages, Cerebral Brain,Hemorrhages, Cerebral Parenchymal,Hemorrhages, Cerebrum,Hemorrhages, Intracerebral,Intracerebral Hemorrhages,Parenchymal Hemorrhage, Cerebral,Parenchymal Hemorrhages, Cerebral
D000316 Adrenergic alpha-Agonists Drugs that selectively bind to and activate alpha adrenergic receptors. Adrenergic alpha-Receptor Agonists,alpha-Adrenergic Receptor Agonists,Adrenergic alpha-Agonist,Adrenergic alpha-Receptor Agonist,Receptor Agonists, Adrenergic alpha,Receptor Agonists, alpha-Adrenergic,alpha-Adrenergic Agonist,alpha-Adrenergic Agonists,alpha-Adrenergic Receptor Agonist,Adrenergic alpha Agonist,Adrenergic alpha Agonists,Adrenergic alpha Receptor Agonist,Adrenergic alpha Receptor Agonists,Agonist, Adrenergic alpha-Receptor,Agonist, alpha-Adrenergic,Agonist, alpha-Adrenergic Receptor,Agonists, Adrenergic alpha-Receptor,Agonists, alpha-Adrenergic,Agonists, alpha-Adrenergic Receptor,Receptor Agonist, alpha-Adrenergic,Receptor Agonists, alpha Adrenergic,alpha Adrenergic Agonist,alpha Adrenergic Agonists,alpha Adrenergic Receptor Agonist,alpha Adrenergic Receptor Agonists,alpha-Agonist, Adrenergic,alpha-Agonists, Adrenergic,alpha-Receptor Agonist, Adrenergic,alpha-Receptor Agonists, Adrenergic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013356 Subfornical Organ A structure, situated close to the intraventricular foramen, which induces DRINKING BEHAVIOR after stimulation with ANGIOTENSIN II. Organum Subfornicale,Organ, Subfornical,Organs, Subfornical,Organum Subfornicales,Subfornical Organs,Subfornicale, Organum,Subfornicales, Organum
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D017551 Microdialysis A technique for measuring extracellular concentrations of substances in tissues, usually in vivo, by means of a small probe equipped with a semipermeable membrane. Substances may also be introduced into the extracellular space through the membrane.

Related Publications

J Tanaka, and Y Hayashi, and T Watai, and K Hori, and M Nomura
September 2002, Autonomic neuroscience : basic & clinical,
J Tanaka, and Y Hayashi, and T Watai, and K Hori, and M Nomura
September 2016, Neuroscience letters,
J Tanaka, and Y Hayashi, and T Watai, and K Hori, and M Nomura
June 2003, Peptides,
J Tanaka, and Y Hayashi, and T Watai, and K Hori, and M Nomura
June 2017, Neuroreport,
J Tanaka, and Y Hayashi, and T Watai, and K Hori, and M Nomura
January 2006, Autonomic neuroscience : basic & clinical,
J Tanaka, and Y Hayashi, and T Watai, and K Hori, and M Nomura
August 1997, Neuroendocrinology,
J Tanaka, and Y Hayashi, and T Watai, and K Hori, and M Nomura
October 2016, Physiology & behavior,
J Tanaka, and Y Hayashi, and T Watai, and K Hori, and M Nomura
March 2003, Behavioural brain research,
J Tanaka, and Y Hayashi, and T Watai, and K Hori, and M Nomura
July 1979, The American journal of physiology,
J Tanaka, and Y Hayashi, and T Watai, and K Hori, and M Nomura
July 1984, Brain research bulletin,
Copied contents to your clipboard!